Advantage Dental Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3

Organization Overview

First Clinical Trial
2016
NCT02536040
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Advantage Dental Plans | Advantage Dental Services, LLC

Active Ingredients

Drugs in Phase 3 Trials (1)

silver diammine fluoride (1 trial)

Drugs in Phase 2 Trials (2)

povidone-iodine (betadine) (1 trial)

sodium fluoride (18F) (1 trial)

Drugs in Phase 1 Trials (1)

sulindac (clinoril) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dental Caries (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 4